Showing 281 - 300 results of 12,700 for search '"cancers"', query time: 0.07s Refine Results
  1. 281
  2. 282
  3. 283

    Distinguishing between HPV-Associated Metastatic Anal Squamous Cell Cancer and HPV-Associated Oropharyngeal Cancer by Steven Sorscher

    Published 2020-01-01
    “…Described here are assays that might be considered in distinguishing between whether a focus distant from a previously identified ASCC represents metastatic disease or instead a separate primary HPV-related cancer.…”
    Get full text
    Article
  4. 284

    MEK Inhibition Targets Cancer Stem Cells and Impedes Migration of Pancreatic Cancer Cells In Vitro and In Vivo by Karolin Walter, Kanishka Tiwary, Marija Trajkovic-Arsic, Ana Hidalgo-Sastre, Laura Dierichs, Sven T. Liffers, Jiangning Gu, Johann Gout, Lucas-Alexander Schulte, Jan Münch, Thomas Seufferlein, Bruno Sainz, Jens T. Siveke, Eva Rodriguez-Aznar, Patrick C. Hermann

    Published 2019-01-01
    “…The vast majority of pancreatic cancers harbor RAS mutations. The outstanding relevance of the RAS/MEK/ERK pathway in pancreatic cancer biology has been extensively shown previously. …”
    Get full text
    Article
  5. 285

    Self-managed physical activity in cancer survivors for the management of cancer-related fatigue: A scoping review. by Isabella Campanini, Maria Bernadette Ligabue, Maria Chiara Bò, Maria Chiara Bassi, Mirco Lusuardi, Andrea Merlo

    Published 2022-01-01
    “…<h4>Objective</h4>Cancer-related fatigue (CRF) is a disabling chronic condition that cancer survivors could experience during and after recovery and that might benefit from self-managed physical activity (PA) programs. …”
    Get full text
    Article
  6. 286

    Involvement of PPARs in Cell Proliferation and Apoptosis in Human Colon Cancer Specimens and in Normal and Cancer Cell Lines by G. Martinasso, M. Oraldi, A. Trombetta, M. Maggiora, O. Bertetto, R. A. Canuto, G. Muzio

    Published 2007-01-01
    “…“In vivo” PPARγ and α were evaluated in colon cancer specimens and adjacent nonneoplastic colonic mucosa. …”
    Get full text
    Article
  7. 287
  8. 288

    MHC Class 1 and PDL-1 Status of Primary Tumor and Lymph Node Metastatic Tumor Tissue in Gastric Cancers by Ibrahim Halil Erdogdu

    Published 2019-01-01
    “…The prognosis of metastatic gastric cancer is poor. Despite the use of VEGF-, EGFR-, and HER2-targeting agents, prognosis is still poor in advanced gastric cancer. …”
    Get full text
    Article
  9. 289
  10. 290

    TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor developed for the treatment of MTAP-deleted cancers by Kimberly J. Briggs, Kevin M. Cottrell, Matthew R. Tonini, Alice Tsai, Minjie Zhang, Douglas A. Whittington, Wenhai Zhang, Steven A. Lombardo, Satoshi Yoda, Erik W. Wilker, Samuel R. Meier, Yi Yu, Teng Teng, Alan Huang, John P. Maxwell

    Published 2025-02-01
    “…MTAP deletion occurs in 10–15 % of all human cancer representing multiple histologies. MTA is a negative regulator of PRMT5 that accumulates as a result of MTAP deletion. …”
    Get full text
    Article
  11. 291

    Upper Gastrointestinal Endoscopy Detection of Synchronous Multiple Primary Cancers in Esophagus and Stomach: Single Center Experience from China by Rui Wang, Mo-Jin Wang, Jin-Lin Yang, Cheng-Wei Tang

    Published 2012-01-01
    “…The present study was undertaken to clarify the prevalence and clinicopathological features of synchronous multiple primary cancers (SMPCs) under upper gastrointestinal endoscopic examination. …”
    Get full text
    Article
  12. 292

    Cytochrome P450 Metabolism of Betel Quid-Derived Compounds: Implications for the Development of Prevention Strategies for Oral and Pharyngeal Cancers by Che-Yi Lin, Tien-Szu Pan, Chun-Chan Ting, Shih-Shin Liang, Shu-Hung Huang, Hsiu-Yueh Liu, Edward Cheng-Chuan Ko, Chung-Wei Wu, Jen-Yang Tang, Ping-Ho Chen

    Published 2013-01-01
    “…Betel quid (BQ) products, with or without tobacco, have been classified by the International Agency for Research on Cancer (IARC) as group I human carcinogens that are associated with an elevated risk of oral potentially malignant disorders (OPMDs) and cancers of the oral cavity and pharynx. …”
    Get full text
    Article
  13. 293
  14. 294
  15. 295

    Covid-19 e Câncer do Colo do Útero: Análise do Registro Hospitalar de Câncer do Instituto Nacional de Câncer no Rio de Janeiro by Monique Villa Real Ayala, Maria Tereza Fonseca da Costa

    Published 2025-01-01
    “… Introdução: O câncer do colo do útero continua sendo um problema de saúde pública apesar da possibilidade de rastreamento e diagnóstico precoce. …”
    Get full text
    Article
  16. 296
  17. 297
  18. 298

    Morbidity of Inguinofemoral Lymphadenectomy in Vulval Cancer by A. A. Soliman, M. Heubner, R. Kimmig, P. Wimberger

    Published 2012-01-01
    “…The aim of this study is to detect possible risk factors for development of short- and long-term local complications after inguinofemoral lymphadenectomy for vulval cancer. Methods. This retrospective cohort study included 34 vulval cancer patients that received inguinofemoral lymphadenectomy. …”
    Get full text
    Article
  19. 299

    PPAR𝛾, PTEN, and the Fight against Cancer by Rosemary E. Teresi, Kristin A. Waite

    Published 2008-01-01
    “…These results are supported by observations of the beneficial effects of PPAR𝛾 agonists in the in vivo cancer setting. These studies signify the importance of PPAR𝛾 and PTEN's interaction in cancer prevention.…”
    Get full text
    Article
  20. 300